Iqvia Holdings Inc (IQV) Stock Price, Quote & News

Company Profile

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions th...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 919 998 2000

Website: www.iqvia.com

Address:

2400 Ellis Road, Durham, United States

BiotechBonesaw Sep. 19 at 1:22 PM

$TNXP agreed. Partnership with $IQV is my top guess as well 🚀 holding long and buying dips 🏦

0 · Reply

MoneyGroupLLC Sep. 18 at 5:44 PM

Enter: $IQV OCT 17 2025 $190 CALLS Buy in Price: $6.70 - $7.20 Take Profit: $16.49 Stop Bleeding: $6.34 ROI Potential: 129% Exit Within: 71 Minutes https://moneygroup.us/alerts

0 · Reply

BiotechBonesaw Sep. 16 at 6:22 PM

$TNXP my guess is they’re partnering with IQVIA for the contracted sales organization. It’s also likely who they’re buying pharma demand data from them that Eversana has been using for their claims analysis. Any other guesses? News coming any day now… ⏰ $IQV 🧐

1 · Reply

StockAutoPro Sep. 15 at 1:10 AM

$IQV: Buy target $185.22 Sell target $196.58 Strong earnings growth potential makes this healthcare data firm an interesting investment opportunity.

0 · Reply

StockAutoPro Sep. 14 at 3:59 PM

$IQV: Buy target $185.22 Sell target $196.58 Strong earnings growth suggests potential bullish trend for a prominent healthcare data analytics firm.

0 · Reply

iriepett Sep. 10 at 4:43 PM

$IQV

0 · Reply

traderhr Sep. 10 at 9:59 AM

The chart for IQV shows a recent symmetrical triangle pattern with potential breakout signals. Price is testing upper resistance levels, while the Bollinger Bands indicate reduced volatility $IQV #tradeideas #swingtrading $SPX https://www.traderhr.com/charts-to-watch-iqv-2/

0 · Reply

topstockalerts Sep. 9 at 7:29 PM

Jefferies upgraded IQVIA Holdings and Charles River Laboratories to Buy while cutting ICON to Hold. IQVIA was named top pick, with stronger client wins, stable trends, and less reliance on single customers; price target raised to $225. ICON faces client losses, project cancellations near $ 1B in Q3, and biotech weakness, leading to a price target cut to $175. Charles River gained on stronger bookings, safety-testing demand, and potential value from a manufacturing unit sale, with a $195 target. Jefferies stayed cautious on Medpace (valuation) and Fortrea (execution risks). $IQV $CRL $ICLR $ICON

1 · Reply

JarvisFlow Sep. 9 at 11:00 AM

Jefferies updates rating for IQVIA Hldgs ( $IQV ) to Buy, target set at 195 → 225.

0 · Reply

StockAutoPro Sep. 7 at 5:13 PM

$IQV: Buy target $185.68 Sell target $197.06 Strong earnings growth potential makes this IQV sector stock a promising long-term investment.

0 · Reply

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

Sep 11, 2025, 2:00 AM EDT - 8 days ago

IQVIA: A Positive Long-Term Outlook Despite Trump Legislation

Sep 10, 2025, 8:00 AM EDT - 9 days ago

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

Sep 2, 2025, 9:41 AM EDT - 17 days ago

IQVIA names Michael Fedock as financial chief

Sep 2, 2025, 9:00 AM EDT - 17 days ago

IQVIA Announces CFO Transition in Early 2026

Aug 28, 2025, 8:00 AM EDT - 22 days ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX MRNA SANA

Aug 19, 2025, 12:00 PM EDT - 4 weeks ago

The Big 3: BLDR, IQV, LOW

BLDR LOW

Aug 18, 2025, 9:00 AM EDT - 4 weeks ago

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

VEEV

Jul 22, 2025, 5:40 PM EDT - 2 months ago

IQVIA: Q2 Earnings Exceeded My Expectations

Jul 22, 2025, 2:00 PM EDT - 2 months ago

IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 8:42 AM EDT - 2 months ago

IQVIA beats quarterly estimates on resilient demand for healthcare analytics

Jul 22, 2025, 7:00 AM EDT - 2 months ago

IQVIA Reports Second-Quarter 2025 Results

Jul 16, 2025, 7:54 AM EDT - 2 months ago

IQVIA: Competition Is Creating More Challenges Over The Long Haul

Jul 1, 2025, 7:00 AM EDT - 2 months ago

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

Jun 16, 2025, 9:00 AM EDT - 3 months ago

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement'

Jun 11, 2025, 7:00 AM EDT - 3 months ago

IQVIA Launches New AI Agents for Life Sciences and Healthcare

Jun 10, 2025, 2:23 PM EDT - 3 months ago

IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?

Jun 2, 2025, 4:37 PM EDT - 3 months ago

IQVIA Announces Pricing of Senior Notes

Jun 2, 2025, 8:10 AM EDT - 3 months ago

IQVIA Announces Offering of Senior Notes

May 27, 2025, 7:00 AM EDT - 4 months ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

RNTX

May 16, 2025, 8:00 AM EDT - 4 months ago

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

May 9, 2025, 1:48 PM EDT - 4 months ago

IQVIA: Q1 Earnings Support Steady Optimism

May 7, 2025, 4:15 PM EDT - 4 months ago

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13

May 6, 2025, 3:04 PM EDT - 4 months ago

IQVIA Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:00 AM EDT - 4 months ago

IQVIA Reports First-Quarter 2025 Results

Apr 28, 2025, 9:00 AM EDT - 5 months ago

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

Apr 23, 2025, 9:00 AM EDT - 5 months ago

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

Apr 21, 2025, 4:15 PM EDT - 5 months ago

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

Apr 15, 2025, 8:00 AM EDT - 5 months ago

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report

Mar 10, 2025, 9:00 AM EDT - 6 months ago

IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services

Mar 4, 2025, 9:00 AM EST - 7 months ago

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

Feb 25, 2025, 3:00 PM EST - 7 months ago

Global Healthy Living Foundation and IQVIA Institute Report Millions of Adult Vaccines Likely Missed When States Restrict Pharmacist Participation

Feb 24, 2025, 9:00 AM EST - 7 months ago

IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence

Feb 21, 2025, 9:00 AM EST - 7 months ago

IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025

Feb 20, 2025, 10:06 AM EST - 7 months ago

IQVIA Releases 2024 Sustainability Report

Feb 16, 2025, 3:36 AM EST - 7 months ago

IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way

Feb 6, 2025, 11:58 AM EST - 8 months ago

IQVIA Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 11:37 AM EST - 8 months ago

IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions

Feb 6, 2025, 8:34 AM EST - 8 months ago

IQVIA beats quarterly results estimates on analytics services demand

Feb 6, 2025, 7:00 AM EST - 8 months ago

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

Feb 4, 2025, 11:00 AM EST - 8 months ago

IQVIA named to the Fortune® World's Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year

Jan 21, 2025, 4:15 PM EST - 8 months ago

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

Jan 13, 2025, 9:00 AM EST - 8 months ago

IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions

Dec 23, 2024, 8:00 AM EST - 9 months ago

Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute

Dec 12, 2024, 8:29 AM EST - 10 months ago

IQVIA Holdings: Share Price Disconnected From Growth Outlook

Nov 6, 2024, 4:15 PM EST - 11 months ago

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024

Oct 31, 2024, 3:52 PM EDT - 11 months ago

IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 12:50 PM EDT - 11 months ago

IQVIA lowers annual revenue forecast amid trial delays

Oct 31, 2024, 7:00 AM EDT - 11 months ago

IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day

Oct 15, 2024, 4:15 PM EDT - 1 year ago

IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024

BiotechBonesaw Sep. 19 at 1:22 PM

$TNXP agreed. Partnership with $IQV is my top guess as well 🚀 holding long and buying dips 🏦

0 · Reply

MoneyGroupLLC Sep. 18 at 5:44 PM

Enter: $IQV OCT 17 2025 $190 CALLS Buy in Price: $6.70 - $7.20 Take Profit: $16.49 Stop Bleeding: $6.34 ROI Potential: 129% Exit Within: 71 Minutes https://moneygroup.us/alerts

0 · Reply

BiotechBonesaw Sep. 16 at 6:22 PM

1 · Reply

StockAutoPro Sep. 15 at 1:10 AM

$IQV: Buy target $185.22 Sell target $196.58 Strong earnings growth potential makes this healthcare data firm an interesting investment opportunity.

0 · Reply

StockAutoPro Sep. 14 at 3:59 PM

$IQV: Buy target $185.22 Sell target $196.58 Strong earnings growth suggests potential bullish trend for a prominent healthcare data analytics firm.

0 · Reply

iriepett Sep. 10 at 4:43 PM

$IQV

0 · Reply

traderhr Sep. 10 at 9:59 AM

0 · Reply

topstockalerts Sep. 9 at 7:29 PM

1 · Reply

JarvisFlow Sep. 9 at 11:00 AM

Jefferies updates rating for IQVIA Hldgs ( $IQV ) to Buy, target set at 195 → 225.

0 · Reply

StockAutoPro Sep. 7 at 5:13 PM

$IQV: Buy target $185.68 Sell target $197.06 Strong earnings growth potential makes this IQV sector stock a promising long-term investment.

0 · Reply

StockAutoPro Sep. 5 at 7:58 PM

$IQV: Buy target $185.54 Sell target $196.92 Strong financials and innovative approach make this IQV sector stock a promising long-term investment.

0 · Reply

traderhr Sep. 2 at 1:12 PM

The stock displayed a consolidation pattern within a narrowing range, indicated by the converging trend lines. The recent price action is testing the upper resistance while maintaining support $IQV #tradeideas #swingtrading $SPX https://www.traderhr.com/charts-to-watch-iqv/

0 · Reply

StockAutoPro Aug. 31 at 5:41 AM

$IQV: Buy target $188.81 Sell target $200.35 Strong earnings report indicates robust growth potential in this leading global healthcare data analytics company.

0 · Reply

LevelUpLife Aug. 27 at 10:04 AM

$IQV volatile swings, risk management key here.

0 · Reply

StockAutoPro Aug. 23 at 4:09 PM

$IQV: Buy target $189.15 Sell target $200.71 Consider investing in the health data analytics sector as telemedicine continues to surge in popularity.

0 · Reply

OptionRunners Aug. 21 at 6:45 PM

$IQV Buyer of the December 19th $190 puts (ITM) 1,500 times for $14.70

0 · Reply

UbetMoney Aug. 18 at 3:19 PM

$IQV today’s news about the peace treaty between them and $VEEV will be extremely beneficial to both parties and the pharmaceutical industry even more so. I can see this lifting both companies to the 30 point plus side over the next 3-6 months alone.

0 · Reply

StockAutoPro Aug. 12 at 3:12 AM

$IQV: Buy target $178.09 Sell target $189.09 Consider investing in this leading player in health data and analytics for potential growth.

0 · Reply

NVDAMillionaire Jul. 30 at 8:35 PM

$IQV Really good write-up that perfectly summarizes IQV's present situation. So if you want to bring your IQV knowledge up to date or just discover IQV, this is required reading. https://beyondspx.com/article/iqvia-s-connected-intelligence-powers-through-sector-headwinds-nyse-iqv

0 · Reply

OnlyFibs Jul. 27 at 8:08 PM

$IQV - keep it simple, MOST buy volume EVER on this weekly, chart, you think the party is over, hell to the no, we just getting warmed up, get comfy and watch the show! #hovdid

0 · Reply

JarvisFlow Jul. 25 at 5:34 PM

Mizuho has updated their rating for IQVIA Hldgs ( $IQV ) to Outperform with a price target of 225.

0 · Reply

IN0V8 Jul. 24 at 3:41 PM

$IQV Opportunity Argus Research raises target price to $230 from $180

0 · Reply

Market Cap	32.33B
Revenue (ttm)	15.41B
Net Income (ttm)	1.37B
EPS (ttm)	N/A
PE Ratio	17.93
Forward PE	17.39
Profit Margin	8.91%
Debt to Equity Ratio	2.68

Volume	2,104,100
Avg Vol	1,680,718
Day's Range	N/A - N/A
Shares Out	170.00M
Stochastic %K	47%
Beta	1.32
Analysts	Strong Sell
Price Target	$215.43